Indicators

Latest News about ORTX

Recent news which mentions ORTX

< Previous 1 2 Next >

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More

May 12, 2022

Orchard Therapeutics: Q1 Earnings Insights

May 12, 2022

Earnings Scheduled For May 12, 2022

May 12, 2022

Orchard Therapeutics Earnings Preview

May 11, 2022

Executives Buy More Than $1.5M Of 3 Penny Stocks

April 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

April 01, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

March 31, 2022

Orchard Therapeutics Plans To Seek Strategic Options For Immunodeficiency Programs, Cuts Workforce

March 30, 2022

Earnings Scheduled For March 30, 2022

March 30, 2022

Recap: Orchard Therapeutics Q4 Earnings

March 30, 2022

Orchard Therapeutics Earnings Preview

March 29, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

March 24, 2022

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

December 29, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021

November 16, 2021

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

October 12, 2021

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results

October 07, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

October 05, 2021

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO

October 01, 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

September 30, 2021

18 Stocks Moving in Tuesday's Pre-Market Session

September 21, 2021

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout

September 14, 2021

Stocks That Hit 52-Week Lows On Friday

August 20, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2021

August 18, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

Stocks That Hit 52-Week Lows On Tuesday

August 17, 2021

The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

August 17, 2021

Stocks That Hit 52-Week Lows On Monday

August 16, 2021

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.